<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>SCN1A-pathway</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 900px;
            margin: 0 auto;
            padding: 20px;
            background: #f5f5f5;
        }
        .content {
            background: white;
            padding: 30px;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        h1, h2, h3, h4, h5, h6 {
            color: #2c3e50;
            margin-top: 24px;
            margin-bottom: 16px;
        }
        h1 { border-bottom: 2px solid #3498db; padding-bottom: 10px; }
        h2 { border-bottom: 1px solid #ecf0f1; padding-bottom: 8px; }
        code {
            background: #f4f4f4;
            padding: 2px 6px;
            border-radius: 3px;
            font-family: 'Courier New', monospace;
        }
        pre {
            background: #2c3e50;
            color: #ecf0f1;
            padding: 15px;
            border-radius: 5px;
            overflow-x: auto;
        }
        pre code {
            background: none;
            padding: 0;
            color: inherit;
        }
        blockquote {
            border-left: 4px solid #3498db;
            margin-left: 0;
            padding-left: 20px;
            color: #555;
        }
        table {
            border-collapse: collapse;
            width: 100%;
            margin: 20px 0;
        }
        th, td {
            border: 1px solid #ddd;
            padding: 12px;
            text-align: left;
        }
        th {
            background: #3498db;
            color: white;
        }
        tr:nth-child(even) {
            background: #f9f9f9;
        }
        .mermaid {
            text-align: center;
            margin: 30px 0;
            background: white;
            padding: 20px;
            border-radius: 8px;
            border: 1px solid #e0e0e0;
        }
        .mermaid svg {
            max-width: 100%;
            height: auto;
        }
        a {
            color: #3498db;
            text-decoration: none;
        }
        a:hover {
            text-decoration: underline;
        }
        .toc {
            background: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 5px;
            padding: 15px;
            margin-bottom: 20px;
        }
        .toc ul {
            list-style-type: none;
            padding-left: 20px;
        }
        .toc > ul {
            padding-left: 0;
        }
    </style>
    
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        // Initialize mermaid with custom settings
        mermaid.initialize({ 
            startOnLoad: true,
            theme: 'default',
            themeVariables: {
                primaryColor: '#3498db',
                primaryTextColor: '#fff',
                primaryBorderColor: '#2c3e50',
                lineColor: '#333',
                secondaryColor: '#ecf0f1',
                tertiaryColor: '#f39c12'
            },
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="content">
        <h1 id="pathway-summary-for-scn1a">Pathway Summary for SCN1A</h1>
<h2 id="overview">Overview</h2>
<p>SCN1A encodes the pore-forming α-subunit of Nav1.1, the most clinically important voltage-gated sodium channel in epilepsy genetics. Nav1.1 directly mediates the depolarizing phase of action potentials through voltage-dependent conformational switching that allows selective Na+ influx. The channel is particularly critical in GABAergic interneurons where it regulates inhibitory neuron excitability - loss-of-function mutations impair interneuron function leading to network hyperexcitability and seizures. SCN1A mutations cause &gt;80% of Dravet syndrome cases.</p>
<h2 id="core-signaling-pathways">Core Signaling Pathways</h2>
<h3 id="action-potential-generation">Action Potential Generation</h3>
<p>Nav1.1 mediates the rapid depolarization phase of action potentials:<br />
- Voltage sensing via S4 segments triggers channel opening<br />
- Selective Na+ permeation through the pore domain<br />
- Fast inactivation terminates Na+ influx<br />
- Recovery from inactivation enables repetitive firing</p>
<h3 id="gabaergic-interneuron-function">GABAergic Interneuron Function</h3>
<p>Nav1.1 is enriched in parvalbumin-positive interneurons where it:<br />
- Enables high-frequency firing patterns<br />
- Maintains inhibitory tone in neural circuits<br />
- Supports feedforward and feedback inhibition<br />
- Loss of function causes disinhibition and seizures</p>
<h3 id="axon-initial-segment-signaling">Axon Initial Segment Signaling</h3>
<p>Nav1.1 concentrates at the axon initial segment (AIS) where it:<br />
- Initiates action potentials<br />
- Sets neuronal excitability threshold<br />
- Integrates synaptic inputs<br />
- Maintains AIS molecular organization</p>
<h2 id="pathway-diagram">Pathway Diagram</h2>
<div class="mermaid">
graph TD
    A[Membrane Depolarization] --> B["Nav1.1: Voltage Sensor (S4)"]
    B --> C[Channel Opening]
    C --> D[Na+ Influx]
    D --> E[Action Potential Upstroke]

    F[Fast Inactivation] --> G[Channel Closure]
    E --> F

    H[Recovery] --> I[Available for Activation]
    G --> H

    J[GABAergic Interneuron] --> K[High Nav1.1 Expression]
    K --> L[Sustained High-Frequency Firing]
    L --> M[Inhibitory Output]
    M --> N[Network Balance]

    O[SCN1A Mutation] --> P[Nav1.1 Loss of Function]
    P --> Q[Interneuron Hypoexcitability]
    Q --> R[Disinhibition]
    R --> S[Seizures]

    T[β-subunits] -.->|modulate| B
    U[FGF14] -.->|regulate| B
    V[Ankyrin-G] -->|anchor at AIS| B

    style B fill:#f9f,stroke:#333,stroke-width:2px
    style S fill:#fdd,stroke:#333,stroke-width:1px
</div>

<h2 id="molecular-properties">Molecular Properties</h2>
<ul>
<li><strong>Voltage dependence</strong>: Activation ~-40 to -30 mV</li>
<li><strong>Ion selectivity</strong>: Na+ &gt;&gt; K+ (~10:1)</li>
<li><strong>Inactivation kinetics</strong>: Fast (&lt;2 ms) and slow components</li>
<li><strong>Recovery time</strong>: 5-10 ms at -80 mV</li>
</ul>
<h2 id="subcellular-localization">Subcellular Localization</h2>
<ul>
<li><strong>Axon initial segment</strong>: Action potential initiation</li>
<li><strong>Nodes of Ranvier</strong>: Saltatory conduction</li>
<li><strong>Soma</strong>: Contributing to excitability</li>
<li><strong>Presynaptic terminals</strong>: Neurotransmitter release</li>
</ul>
<h2 id="clinical-significance">Clinical Significance</h2>
<h3 id="dravet-syndrome">Dravet Syndrome</h3>
<ul>
<li><strong>&gt;80% caused by SCN1A mutations</strong></li>
<li>Severe myoclonic epilepsy of infancy</li>
<li>Developmental delays and cognitive impairment</li>
<li>Status epilepticus risk</li>
</ul>
<h3 id="gefs-genetic-epilepsy-with-febrile-seizures-plus">GEFS+ (Genetic Epilepsy with Febrile Seizures Plus)</h3>
<ul>
<li>Milder phenotype with febrile seizures</li>
<li>Variable penetrance and expressivity</li>
<li>Often missense mutations</li>
</ul>
<h3 id="treatment-implications">Treatment Implications</h3>
<ul>
<li><strong>Contraindicated</strong>: Sodium channel blockers worsen seizures</li>
<li><strong>Beneficial</strong>: Drugs enhancing GABAergic function</li>
<li><strong>Precision medicine</strong>: Genotype-guided therapy</li>
</ul>
<h2 id="regulatory-mechanisms">Regulatory Mechanisms</h2>
<ul>
<li><strong>β-subunits (SCN1B-4B)</strong>: Modulate gating and trafficking</li>
<li><strong>FGF14</strong>: Regulates channel availability</li>
<li><strong>Ankyrin-G</strong>: AIS anchoring and clustering</li>
<li><strong>Phosphorylation</strong>: PKA/PKC modulation</li>
<li><strong>Temperature sensitivity</strong>: Enhanced dysfunction with fever</li>
</ul>
<h2 id="functional-integration">Functional Integration</h2>
<ul>
<li><strong>E/I balance</strong>: Critical for maintaining inhibitory tone</li>
<li><strong>Network oscillations</strong>: Supports gamma rhythms via interneurons</li>
<li><strong>Developmental regulation</strong>: Expression increases postnatally</li>
<li><strong>Compensation mechanisms</strong>: Other Nav channels partially compensate</li>
</ul>
    </div>
    <footer style="text-align: center; padding: 20px; color: #666;">
        <small>Generated from SCN1A-pathway.md</small>
    </footer>
</body>
</html>